IDSA recommends combination for both staphylococcal and streptococcal TSS
IVIG evidence base
Mechanism of IVIG action
Polyclonal antibodies neutralize superantigens
Reduces cytokine storm
May modulate complement activation
Clinical evidence
Single RCT (INSTINCT trial) showed trend toward mortality benefit in streptococcal TSS
Observational data supports IVIG in refractory streptococcal TSS
Staphylococcal TSS evidence weaker but IVIG considered in refractory cases
Source control primacy
Source control as definitive treatment
Antibiotics alone insufficient while toxin source persists
Removal of foreign body or debridement reduces ongoing toxin load
Earlier source control associated with improved outcomes
Timing of surgical intervention
Necrotizing fasciitis — within 6 hours of diagnosis
Each hour delay increases mortality
Do not delay surgery for imaging confirmation if clinical diagnosis certain
Patient Discharge Instructions
copy discharge instructions
Toxic Shock Syndrome — Discharge Instructions
What is Toxic Shock Syndrome
A severe infection caused by toxins produced by bacteria
Can affect multiple organs rapidly if not treated
You have been treated for this in hospital
Medications to complete
Take all prescribed antibiotics as directed
Complete the full antibiotic course even if feeling better
Anti-staphylococcal antibiotics are required to prevent recurrence of menstrual TSS
Activity and recovery
Expect prolonged fatigue for weeks to months after discharge
Hair loss and nail changes may occur — usually reversible
Memory difficulties and concentration problems may persist
Tampon and menstrual product advice (if applicable)
Do not use tampons for at least 3–6 months
When resuming, use lowest-absorbency tampons
Change tampons every 4–8 hours — do not use overnight
Consider alternative menstrual products going forward
Follow-up appointments
Infectious disease follow-up within 1–2 weeks
Primary care follow-up within 1 week of discharge
Repeat blood tests to confirm organ recovery as directed
Return to emergency department immediately for
Recurrent fever
Return of rash or new skin changes
Dizziness, lightheadedness, or fainting
Vomiting or severe diarrhea
Confusion or difficulty thinking clearly
Decreased urine output
Any new or worsening symptoms
References
Guidelines and key sources
Primary guidelines and landmark references
Gottlieb M, Long B, Koyfman A — The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department
Journal of Emergency Medicine 2018 (PMID 29366615)
Comprehensive emergency medicine review
Lappin E, Ferguson AJ — Gram-Positive Toxic Shock Syndromes
Lancet Infectious Diseases 2009 (PMID 19393958)
Core pathophysiology and management review
Berger S et al — Menstrual Toxic Shock Syndrome: Case Report and Systematic Review
Lancet Infectious Diseases 2019 (PMID 31151811)
Systematic review of menstrual TSS
Society guidelines
Stevens DL et al — IDSA Guidelines for Skin and Soft Tissue Infections 2014
Clinical Infectious Diseases 2014
Streptococcal TSS antibiotic recommendations — penicillin G plus clindamycin
Wilkins AL et al — Toxic Shock Syndrome: The Seven Rs of Management and Treatment
Journal of Infection 2017 (PMID 28646955)
Systematic management framework
Supporting studies
Chuang YY, Huang YC, Lin TY — Toxic Shock Syndrome in Children
Paediatric Drugs 2005 (PMID 15777108)
Pediatric epidemiology, dosing, and management
Billon A et al — Association of Tampon Use With Menstrual TSS in France
EClinicalMedicine 2020 (PMID 32382713)
Tampon risk factors and menstrual TSS characteristics
Hua C et al — Necrotising Soft-Tissue Infections
Lancet Infectious Diseases 2023 (PMID 36252579)
Surgical source control evidence
Tofte RW, Williams DN — Clinical and Laboratory Manifestations of Toxic Shock Syndrome
Annals of Internal Medicine 1982 (PMID 6212006)
Classic clinical description and CDC criteria basis
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.